Pharmaxi LLC’s Post

The bold new #innovative solution offered by S-CLINICA integrates Randomization and Trial Supply Management (RTSM) into a single platform. This unique combination brings multiple advantages to sponsors and clinical trial teams: - **BUDGET CONTROL**: This platform reduces supply chain budgets by minimizing overstocking and emergency shipments. - **IMPROVED TRIAL OUTCOMES**: Real-time data synchronization ensures patients receive the correct medication on time, reducing risk. - **ENHANCED VISIBILITY**: Sponsors can access a comprehensive overview of trial progress and supply metrics on a single dashboard, driving data-driven decision-making. - **SCALABILITY**: This platform can accommodate trials of any scale, from early-phase studies to large complex global multi-center trials. S-CLINICA's consolidation of RTSM and supply forecasting streamlines clinical trial management significantly. The platform's customization capability allows for timely trial launches within budget, maintaining quality and compliance. By enhancing process efficiency and data accuracy, S-CLINICA enables sponsors to focus on delivering impactful therapies to patients. Please, reach out to me directly if you’d like to learn more about how S-Clinica’s platform can simplify your next study. Thanks for sharing with your #network #RTSM #supplyforecasting #clinicaltrialmanagement #radiopharmaceuticals #celltherapey #oncology #innovation #technology #management #AI #FDA #clinicaltrials #healthcare #medicine #biotech #pharma #RTSM #supplyforecasting #supplychainmanagement #CDMO #CRO #SCLINICA

Clinical Trials Market Size to Hit US$ 73.2 Billion by 2028 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬:https://lnkd.in/dHR9QaiK The global clinical trials market in terms of revenue was estimated to be worth $48.2 billion in 2023 and is poised to reach $73.2 billion by 2028, growing at a CAGR of 8.7% from 2023 to 2028. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific IQVIA ICON plc Laboratory Corporation of America Holdings Syneos Health WuXi AppTec Charles River Laboratories Fortrea Medpace Frontage Laboratories, Inc ACM Global Laboratories Advanced Clinical PSI CRO AG Bioagile Therapeutics Pvt Ltd CTI Clinical Trial and Consulting Services Worldwide Clinical Trials Pepgra Clinical Research Organization (CRO) for Medicines and Healthcare products CTI Clinical Trial and Consulting Services Dove Quality Solutions Firma Clinical Research Celerion Novotech Linical

Excited to share my latest article on clinical trial supply management! 📈🥼 Clinical trials are becoming more challenging in line with the increased complexity of investigational drugs that focus on personalized medicine, smaller patient populations and rarer indications. In this article, I dive into the 4 top trends influencing this space, and how to de-risk your supply chain. Read the full article here 👉 https://lnkd.in/e2VQcQqB #clinicaltrials #drugdevelopment  

Clinical Trials Market Worth $73.2 Billion by 2028  ☑️𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞:https://lnkd.in/d2u3bTSZ The global clinical trials market in terms of revenue was estimated to be worth $48.2 billion in 2023 and is poised to reach $73.2 billion by 2028, growing at a CAGR of 8.7% from 2023 to 2028. 🔵𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific IQVIA ICON plc Laboratory Corporation of America Holdings Syneos Health WuXi AppTec Charles River Laboratories PAREXEL International (India) Private Ltd Fortrea Medpace Frontage Laboratories, Inc ACM Global Laboratories Advanced Clinical PSI CRO AG Bioagile Therapeutics Pvt Ltd CTI Clinical Trial and Consulting Services Worldwide Clinical Trials Pepgra Clinical Research Organization (CRO) for Medicines and Healthcare products CTI CLINICAL TRIAL AND CONSULTING SERVICES UK LTD Dove Quality Solutions Firma Clinical Research Celerion Novotech Linical

Performance-Driven Approaches to Clinical Trials We are pleased to announce that Atlas Clinical Research CEO Mark Scullion will speak on the panel discussion “Strategic Transformation: Advancing Clinical Trials through Innovative Site Network Commercial Models at a Portfolio Level” at the Patients As Partners in Clinical Research Community News Conference tomorrow, March 20th, at the Sheraton in Philadelphia, PA. Session Overview: Today, clinical trial enrollment sites have a “sunk cost” that could be re-invested into a performance-driven approach. This session introduces a new, portfolio-level approach for greater impact. These approaches may create a paradigm shift in how sponsors, CROs, and Site Networks collaborate, offering a win-win strategy that focuses on consistent, reliable performance rather than constant pursuit. Key Discussion Topics: ✔ How large and mid-size pharmaceutical organizations can redefine enterprise-level frameworks, fostering an aligned approach to recruitment goals. ✔ Innovative reward/risk models that reimagine site compensation, allowing for reinvestment in overall performance at an enterprise portfolio level. Expert Speakers: Samir Shah, Principal at Shah Pharma Consulting Services LLC (Moderator), and fellow panelists EB McLindon, CEO at Helios Clinical, and Carlos E. Orantes, CEO at Alcanza Clinical. It’s the last day to register, so don’t forget to use the discount code below! Hope to see you all there. #clinicaltrials #clinicalresearch #PAP2024 Rachael Brown, Rajat M., Emily Piernick

Tinnitus Treatment Revolutionized as pnq Health Receives FDA Clearance for Integrated Digital Health Platform pnq Health announced that it has received the FDA Clearance as a Class II, Software as a Medical Device for its groundbreaking digital health platform designed to treat tinnitus, one of the world’s most common yet untreated conditions. Unlike traditional approaches that focus solely on the auditory aspect, pnq Health’s model integrates Signal Monitoring Management with internal medicine consultation support via telemedicine, offering a holistic and effective solution for patients that is administered at home and supported by a national network of telehealth medical experts. For more details please click the link! https://lnkd.in/gDWhzjnD #marketaccess #reimbursement #pricing #hta #heor #healtheconomics #medicaldevices #pharmaceutical 

Discover the art of fast-tracking drug development with Miami Clinical Research! In our newest blog, we unveil the tactics and tools driving our success in expediting clinical trials. Join us as we navigate the complex landscape of medical research, delivering efficient and impactful solutions that shape the future of healthcare. Don't miss out—click the link below to uncover the science behind our strategies: https://lnkd.in/gm6mHD7D #medicalresearch #clinicaltrials #medicalstudies #miamiclinicalresearch #drugdevelopment #clinicalresearch #pharmaceuticalresearch #healthcare #drugtrials

❓ How can we enhance recruitment for clinical trials? Traditional methods often fall short in engaging diverse patient populations. Join Circuit Clinical for an insightful webinar exploring how EMR data and personalized engagement strategies can overcome recruitment barriers, improve patient engagement, and ensure trial success. Irfan Khan, MD, CEO of Circuit Clinical, will lead the discussion with expert speakers, including Kelly McKee of AstraZeneca, Melisa Mordenti of Merck, Scott Gucciardi and Meghna Wolfe of NextGen Healthcare, and Kathy Bean of Circuit Clinical. Register now to explore cutting-edge solutions for clinical trial recruitment: https://buff.ly/4fKWmV5 #ClinicalTrials #EMR #Recruitment #Pharmaceuticals #Webinar

Top 5 Challenges of Managing Clinical Trials As a practice in the life sciences industry, clinical trials are essential for developing new drugs and treatment methods. https://lnkd.in/d87WMMYZ

Phase 1 Update 🚀 Exciting Milestone Achieved! 🌟 We are thrilled to announce that Cytonics Corporation's clinical sites are now activated for our Phase 1 study of CYT-108 as a treatment for #osteoarthritis! 🏥 What is Clinical Site Activation? Clinical site activation is a comprehensive process that ensures each site is fully prepared to begin patient recruitment and conduct the clinical trial. This includes obtaining regulatory approvals, training staff, and setting up necessary equipment and systems. 🔬 ✅ Why is This Important? Activating our clinical sites is a pivotal step, ensuring we are ready to conduct our study with the highest standards of accuracy and integrity. This readiness is essential for generating reliable and robust clinical data. 📊 💉 What Does This Mean for Our Study? With our sites now activated, we are ready to begin patient recruitment and start the clinical trial. This significant advancement brings us closer to offering a transformative treatment for osteoarthritis. 🌐 🙏 Stay tuned for more updates as we embark on this exciting phase! #ClinicalResearch #Osteoarthritis #Biotech #HealthcareInnovation #ClinicalTrials #CYT108 #RegenerativeMedicine #Biopharmaceuticals #MedicalResearch #Cytonics